The clinics ofHHV-6 infection inCOVID-19 pandemic: Pityriasis rosea and Kawasaki disease

Basit Öğe Kaydı
dc.contributor.authorDursun, Recep
dc.contributor.authorTemiz, Selami Aykut
dc.date.accessioned2024-02-23T14:24:05Z
dc.date.available2024-02-23T14:24:05Z
dc.date.issued2020
dc.departmentNEÜen_US
dc.description.abstractA new type of coronavirus family (SARS-CoV-2), which can be found in humans and animals, with many varieties and clinical symptoms, was first seen in Wuhan, China in late 2019, under the name novel Coronavirus Disease 2019 (COVID-19). In the literature, cutaneous symptoms related to the disease are generally emphasized. However, it is not yet known whether this new SARS-CoV-2 virus, which has entered our lives, plays a role in the etiopathogenesis of dermatological diseases. The patients who were admitted to the dermatology outpatient clinic between 1 April and 15 May 2019, and on 1 April and 15 May 2020 were retrospectively analyzed by searching the hospital automation system and patient files. The reason for the same months to be included in the study was to exclude seasonal effects on the diseases. After pandemic, the number of patients with Pityriasis rosea and Kawasaki disease increased significantly in patients who applied to the dermatology outpatient clinic. Our study is the first study showing Pityriasis rosea increase during the pandemic period. We think that this increase is related to HHV-6 reactivation. Herein, we wanted to draw attention to two diseases in which Human Herpes 6 (HHV-6) was accused in etiopathogenesis: Kawasaki disease and Pityriasis rosea.en_US
dc.identifier.doi10.1111/dth.13730
dc.identifier.issn1396-0296
dc.identifier.issn1529-8019
dc.identifier.issue4en_US
dc.identifier.pmid32475003en_US
dc.identifier.scopus2-s2.0-85087286748en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1111/dth.13730
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13815
dc.identifier.volume33en_US
dc.identifier.wosWOS:000543938600001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWiley-Hindawien_US
dc.relation.ispartofDermatologic Therapyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid-19en_US
dc.subjectHhv-6en_US
dc.subjectKawasaki Diseaseen_US
dc.subjectPityriasis Roseaen_US
dc.titleThe clinics ofHHV-6 infection inCOVID-19 pandemic: Pityriasis rosea and Kawasaki diseaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu